amdx2011p
Small moleculeexperimentalImaging agent
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 24, 2022 (NCT05542576)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06514001 | Phase 2 | Jul 31, 2024 | Amydis Inc. |
| NCT06223048 | Phase 2 | Dec 7, 2023 | Amydis Inc. |
| NCT05709314 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2023 | Amydis Inc., National Institutes of Health (NIH) |
| NCT05542576 | Phase 1 | Aug 24, 2022 | Amydis Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Amydis Inc. | For profit | 4 | 4 | 2 | 2022 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1